PAR 9.43% 24.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM FILES FIRST IND WITH US FDA, page-20

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 54 Posts.
    lightbulb Created with Sketch. 15

    There is a pre-IND meeting that needs to happen before the IND submission is made.

    During this meeting the board will get a good idea of what the likely outcome of the submission will be.

    It is also a chance for them to get a better understanding of what the FDA will want to see in the submission.

    I don't think the pre-IND meeting has happened yet.

    If the FDA give the green light on the NFL player trial, chances are good they will grant the Phase 3 trial for OA.

    TGA here in Australia will likely reach the same outcome, but not a given.

    .

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.